Opus Genetics Inc (IRD): Next-Year EPS Estimate 32.50%
As of 2026-06-04, Opus Genetics Inc (IRD) has a next-year EPS growth estimate of 32.50%.
On 2026-06-04, analyst consensus for IRD's next-year EPS growth shifted from 33.48% to 32.50% — a negative change of 0.98 percentage points. Current-year growth is projected at -33.83%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 32.50%
- EPS growth this year
- -33.83%
- EPS next quarter (est)
- -$0.15
- Last price
- $4.64
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 32.50% | -33.83% | -$0.15 | $4.64 |
| 2026-06-03 | 33.48% | -37.86% | -$0.16 | $4.20 |
| 2026-06-02 | 33.48% | -37.86% | -$0.16 | $3.99 |
| 2026-06-01 | 33.48% | -37.86% | -$0.16 | $4.12 |
| 2026-05-31 | 33.48% | -37.86% | -$0.16 | $4.36 |
| 2026-05-28 | 33.48% | -37.86% | -$0.16 | $4.20 |
| 2026-05-27 | 30.30% | -32.32% | -$0.16 | $4.14 |
| 2026-05-26 | 30.30% | -32.32% | -$0.16 | $4.09 |
| 2026-05-25 | 30.30% | -32.32% | -$0.16 | $4.26 |
| 2026-05-24 | 30.30% | -32.32% | -$0.16 | $4.26 |
| 2026-05-21 | 30.30% | -32.32% | -$0.16 | $4.29 |
| 2026-05-20 | 30.93% | -31.83% | -$0.15 | $4.44 |
| 2026-05-19 | 30.93% | -31.83% | -$0.15 | $4.26 |
| 2026-05-18 | 30.93% | -31.83% | -$0.15 | $4.44 |
| 2026-05-17 | 30.93% | -31.83% | -$0.15 | $4.80 |
| 2026-05-14 | 30.93% | -31.83% | -$0.15 | $4.97 |
| 2026-05-13 | 25.70% | -20.36% | -$0.14 | $5.03 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Opus Genetics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Opus Genetics Inc (IRD) has a next-year EPS growth estimate of 32.50%, based on analyst consensus.
When was the latest EPS estimate revision for IRD?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 33.48% to 32.50%.
What sector and industry does Opus Genetics Inc belong to?▾
Opus Genetics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IRD appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Opus Genetics Inc (IRD) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports